Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 15,855 shares, an increase of 45.4% from the January 29th total of 10,905 shares. Approximately 1.0% of the company’s stock are sold short. Based on an average daily trading volume, of 14,132 shares, the days-to-cover ratio is presently 1.1 days. Based on an average daily trading volume, of 14,132 shares, the days-to-cover ratio is presently 1.1 days. Approximately 1.0% of the company’s stock are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.
Read Our Latest Report on RKDA
Arcadia Biosciences Stock Up 0.4%
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.
Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.
Recommended Stories
- Five stocks we like better than Arcadia Biosciences
- America’s 1776 happening again
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Your name isn’t on our protected list yet
- Elon Musk already made me a “wealthy man”
- The Biggest IPO Ever… Open to Everyday Folks
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
